Title: A comprehensive assessment of repaglinide metabolic pathways: impact of choice of in vitro system and relative enzyme contribution to in vitro clearance.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120701
1219803-12-9 | 4-Ethylguaiacol-d5 | AA009EPN | MFCD06658672
1246929-01-0 | EltroMbopag Methyl Ester | AA009EX6
1331909-01-3 | Phenylacetyl-d5 L-Glutamine | AA009F54 | MFCD11983484
1246819-63-5 | Methoxsalen-13CD3 | AA009FCM
1217540-34-5 | trans-3'-Hydroxycotinine-O-(4-deoxy-4,5-didehydro)--D-glucuronide, Methyl Ester | AA009FKJ | MFCD09840716
1217201-89-2 | Zonisamide N,N-Dimethylformimidamide | AA009FR4 | MFCD24386561
13521-25-0 | 1H-Pyrazolo[3,4-d]pyridazin-4(5h)-one | AA009GCF | MFCD20040094
1415407-60-1 | (4-Cyclopropyl-3,4-dihydro-1(2H)-quinoxalinyl)[4-(2,5-dimethylphenoxy)-3-pyridinyl]methanone | AA009GND | MFCD30182262
1400264-85-8 | tert-Butyl 3,3-difluoro-4-oxopiperidine-1-carboxylate hydrate | AA009HJT | MFCD16140378
1353955-46-0 | 4-(6-Methoxy-pyriMidin-4-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester | AA009I8V | MFCD21098553